| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR51A4 OR51A2 OR5D16 NPBWR1 NPBWR2 CYSLTR2 OR2AK2 OR10A7 OR5M9 OR2M7 OR8U1 GALR1 GPR50 OR1B1 OR10P1 OR11H4 OR4E2 OR2C3 OR5K4 OR2F1 OR5AR1 ADGRA2 OR6X1 OR8U9 OR51E2 FZD7 OR52B4 TAS2R16 OR5J2 OR5AC2 CELSR2 OR51M1 OR7D2 OR51I2 GPR75 OR52N4 RRH OR51V1 OR8D4 OR4K3 GPR119 CXCR1 | 2.95e-23 | 884 | 144 | 42 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR51A4 OR51A2 OR5D16 CHRNA6 NPBWR1 NPBWR2 CYSLTR2 OR2AK2 OR10A7 OR5M9 OR2M7 OR8U1 GALR1 GPR50 OR1B1 OR10P1 OR11H4 OR4E2 HTR3E OR2C3 OR5K4 OR2F1 OR5AR1 ADGRA2 CHRNA2 CHRNA3 OR6X1 OR8U9 OR51E2 FZD7 OR52B4 TAS2R16 OR5J2 OR5AC2 CELSR2 PTPRR PLXNC1 OR51M1 OR7D2 OR51I2 GPR75 OR52N4 RRH OR51V1 OR8D4 OR4K3 GPR119 CXCR1 | 2.70e-21 | 1353 | 144 | 48 | GO:0004888 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR51A4 OR51A2 OR5D16 OR2AK2 OR10A7 OR5M9 OR2M7 OR8U1 OR1B1 OR10P1 OR11H4 OR4E2 OR2C3 OR5K4 OR2F1 OR5AR1 OR6X1 OR8U9 OR51E2 OR52B4 OR5J2 OR5AC2 OR51M1 OR7D2 OR51I2 OR52N4 OR51V1 OR8D4 OR4K3 | 4.24e-20 | 431 | 144 | 29 | GO:0004984 |
| GeneOntologyMolecularFunction | odorant binding | OR5D16 OR5M9 OR8U1 OR4E2 OR5K4 OR5AR1 OR8U9 OR5J2 OR5AC2 OR8D4 | 2.83e-08 | 127 | 144 | 10 | GO:0005549 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1C TPTE CHRNA6 KCNH7 TPCN2 TMC2 HTR3E TMEM175 ANO5 PKDREJ CHRNA2 CHRNA3 KCND3 KCNH2 SCN5A ANO7 PACC1 | 3.70e-08 | 459 | 144 | 17 | GO:0005216 |
| GeneOntologyMolecularFunction | channel activity | CACNA1C TPTE CHRNA6 KCNH7 TPCN2 TMC2 HTR3E TMEM175 ANO5 PKDREJ CHRNA2 CHRNA3 KCND3 KCNH2 SCN5A ANO7 PACC1 | 2.52e-07 | 525 | 144 | 17 | GO:0015267 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1C TPTE CHRNA6 ATP13A4 KCNH7 TPCN2 ATP7A TMC2 HTR3E TMEM175 ANO5 PKDREJ CHRNA2 CHRNA3 KCND3 KCNH2 UCP1 SCN5A ANO7 PACC1 ATP13A3 | 2.58e-07 | 793 | 144 | 21 | GO:0015075 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1C TPTE CHRNA6 KCNH7 TPCN2 TMC2 HTR3E TMEM175 ANO5 PKDREJ CHRNA2 CHRNA3 KCND3 KCNH2 SCN5A ANO7 PACC1 | 2.59e-07 | 526 | 144 | 17 | GO:0022803 |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1C CHRNA6 KCNH7 TPCN2 TMC2 HTR3E ANO5 CHRNA2 CHRNA3 KCND3 KCNH2 ANO7 PACC1 | 9.36e-07 | 334 | 144 | 13 | GO:0022836 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1C TPTE CHRNA6 ATP13A4 KCNH7 TPCN2 ATP7A TMC2 FLVCR1 HTR3E TMEM175 SLC19A2 ANO5 PKDREJ CHRNA2 CHRNA3 KCND3 KCNH2 UCP1 SCN5A ANO7 PACC1 ATP13A3 SLC51A SLC22A20P | 1.10e-06 | 1180 | 144 | 25 | GO:0022857 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1C CHRNA6 KCNH7 TPCN2 TMC2 HTR3E TMEM175 PKDREJ CHRNA2 CHRNA3 KCND3 KCNH2 SCN5A | 1.26e-06 | 343 | 144 | 13 | GO:0005261 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | CHRNA6 KCNH7 TPCN2 HTR3E ANO5 CHRNA2 CHRNA3 KCNH2 ANO7 PACC1 | 1.41e-06 | 193 | 144 | 10 | GO:0015276 |
| GeneOntologyMolecularFunction | ligand-gated channel activity | CHRNA6 KCNH7 TPCN2 HTR3E ANO5 CHRNA2 CHRNA3 KCNH2 ANO7 PACC1 | 1.70e-06 | 197 | 144 | 10 | GO:0022834 |
| GeneOntologyMolecularFunction | transporter activity | CACNA1C TPTE CHRNA6 ATP13A4 KCNH7 TPCN2 ATP7A TMC2 FLVCR1 HTR3E TMEM175 SLC19A2 ANO5 PKDREJ CHRNA2 CHRNA3 KCND3 KCNH2 UCP1 SCN5A ANO7 PACC1 ATP13A3 SLC51A SLC22A20P | 5.30e-06 | 1289 | 144 | 25 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1C CHRNA6 ATP13A4 KCNH7 TPCN2 ATP7A TMC2 HTR3E TMEM175 PKDREJ CHRNA2 CHRNA3 KCND3 KCNH2 UCP1 SCN5A ATP13A3 | 6.17e-06 | 664 | 144 | 17 | GO:0008324 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 7.08e-05 | 140 | 144 | 7 | GO:0099094 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 2.32e-04 | 17 | 144 | 3 | GO:0022848 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 2.57e-04 | 43 | 144 | 4 | GO:0005231 | |
| GeneOntologyMolecularFunction | superoxide-generating NADPH oxidase activity | 3.07e-04 | 4 | 144 | 2 | GO:0106292 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1C ATP13A4 KCNH7 TPCN2 ATP7A TMC2 TMEM175 ANO5 PKDREJ KCND3 KCNH2 UCP1 SCN5A ANO7 PACC1 | 3.87e-04 | 758 | 144 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1C ATP13A4 KCNH7 TPCN2 ATP7A TMC2 TMEM175 PKDREJ KCND3 KCNH2 SCN5A | 5.64e-04 | 465 | 144 | 11 | GO:0046873 |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 5.85e-04 | 23 | 144 | 3 | GO:0015464 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 7.62e-04 | 57 | 144 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 8.29e-04 | 152 | 144 | 6 | GO:0022843 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 9.25e-04 | 60 | 144 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | G protein-coupled opioid receptor activity | 1.06e-03 | 7 | 144 | 2 | GO:0004985 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.25e-03 | 65 | 144 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.25e-03 | 65 | 144 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1C ATP13A4 KCNH7 TPCN2 ATP7A TMC2 TMEM175 PKDREJ KCND3 KCNH2 UCP1 SCN5A | 1.98e-03 | 627 | 144 | 12 | GO:0022890 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 2.08e-03 | 182 | 144 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 2.12e-03 | 75 | 144 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.20e-03 | 184 | 144 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 2.20e-03 | 36 | 144 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 2.20e-03 | 36 | 144 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 2.34e-03 | 77 | 144 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 2.38e-03 | 37 | 144 | 3 | GO:0042923 | |
| GeneOntologyMolecularFunction | polyamine transmembrane transporter activity | 2.72e-03 | 11 | 144 | 2 | GO:0015203 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization | 3.25e-03 | 12 | 144 | 2 | GO:1902282 | |
| GeneOntologyMolecularFunction | NAD(P)H oxidase H2O2-forming activity | 3.25e-03 | 12 | 144 | 2 | GO:0016174 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 3.25e-03 | 12 | 144 | 2 | GO:0016175 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 4.44e-03 | 46 | 144 | 3 | GO:0005245 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR51A4 OR51A2 OR5D16 OR2AK2 OR10A7 OR5M9 OR2M7 OR8U1 OR1B1 OR10P1 OR11H4 OR4E2 OR2C3 OR5K4 OR2F1 OR5AR1 OR6X1 OR8U9 OR51E2 OR52B4 OR5J2 OR5AC2 OR51M1 OR7D2 OR51I2 OR52N4 OR51V1 OR8D4 OR4K3 | 1.26e-20 | 432 | 142 | 29 | GO:0050911 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR51A4 OR51A2 OR5D16 OR2AK2 OR10A7 OR5M9 OR2M7 OR8U1 OR1B1 OR10P1 OR11H4 OR4E2 OR2C3 OR5K4 OR2F1 OR5AR1 OR6X1 OR8U9 OR51E2 OR52B4 TAS2R16 OR5J2 OR5AC2 OR51M1 OR7D2 OR51I2 OR52N4 OR51V1 OR8D4 OR4K3 | 2.57e-20 | 485 | 142 | 30 | GO:0050907 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR51A4 OR51A2 OR5D16 OR2AK2 OR10A7 OR5M9 OR2M7 OR8U1 OR1B1 OR10P1 OR11H4 OR4E2 OR2C3 OR5K4 OR2F1 OR5AR1 OR6X1 OR8U9 OR51E2 OR52B4 OR5J2 OR5AC2 OR51M1 OR7D2 OR51I2 OR52N4 OR51V1 OR8D4 OR4K3 | 9.53e-20 | 465 | 142 | 29 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR51A4 OR51A2 OR5D16 OR2AK2 OR10A7 OR5M9 OR2M7 OR8U1 OR1B1 OR10P1 OR11H4 OR4E2 OR2C3 OR5K4 OR2F1 OR5AR1 OR6X1 OR8U9 OR51E2 OR52B4 TAS2R16 OR5J2 OR5AC2 OR51M1 OR7D2 OR51I2 OR52N4 OR51V1 OR8D4 OR4K3 | 2.28e-19 | 524 | 142 | 30 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR51A4 OR51A2 OR5D16 OR2AK2 OR10A7 OR5M9 OR2M7 OR8U1 TMC2 OR1B1 OR10P1 OR11H4 OR4E2 OR2C3 OR5K4 OR2F1 OR5AR1 PKDREJ OR6X1 OR8U9 OR51E2 OR52B4 JUP TAS2R16 OR5J2 OR5AC2 OR51M1 OR7D2 OR51I2 OR52N4 RRH OR51V1 OR8D4 OR4K3 | 2.87e-19 | 722 | 142 | 34 | GO:0051606 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR51A4 OR51A2 OR5D16 OR2AK2 OR10A7 OR5M9 OR2M7 OR8U1 TMC2 OR1B1 OR10P1 OR11H4 OR4E2 OR2C3 OR5K4 OR2F1 OR5AR1 OR6X1 OR8U9 OR51E2 OR52B4 TAS2R16 OR5J2 OR5AC2 OR51M1 OR7D2 OR51I2 OR52N4 OR51V1 OR8D4 OR4K3 | 4.21e-19 | 582 | 142 | 31 | GO:0050906 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR51A4 OR51A2 OR5D16 OR2AK2 OR10A7 OR5M9 OR2M7 OR8U1 OR1B1 OR10P1 OR11H4 OR4E2 OR2C3 OR5K4 OR2F1 OR5AR1 OR6X1 OR8U9 OR51E2 OR52B4 TAS2R16 OR5J2 OR5AC2 OR51M1 OR7D2 OR51I2 OR52N4 OR51V1 OR8D4 OR4K3 | 7.56e-19 | 547 | 142 | 30 | GO:0007606 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR51A4 OR51A2 OR5D16 NPBWR1 NPBWR2 CYSLTR2 OR2AK2 OR10A7 OR5M9 OR2M7 OR8U1 GALR1 GPR50 OR1B1 OR10P1 OR11H4 OR4E2 OR2C3 OR5K4 OR2F1 OR5AR1 ADGRA2 OR6X1 OR8U9 OR51E2 FZD7 OR52B4 TAS2R16 OR5J2 OR5AC2 CELSR2 OR51M1 ATRNL1 OR7D2 OR51I2 GPR75 OR52N4 RRH ARRDC3 OR51V1 OR8D4 OR4K3 GPR119 CXCR1 | 2.86e-18 | 1395 | 142 | 44 | GO:0007186 |
| GeneOntologyBiologicalProcess | sensory perception | OR51A4 OR51A2 OR5D16 OR2AK2 OR10A7 OR5M9 OR2M7 OR8U1 TMC2 OR1B1 OR10P1 OR11H4 OR4E2 OR2C3 OR5K4 OR2F1 OR5AR1 OR6X1 OR8U9 OR51E2 OR52B4 TAS2R16 OR5J2 OR5AC2 OR51M1 OR7D2 OR51I2 OR52N4 RRH OR51V1 OR8D4 OR4K3 ANKFN1 | 2.35e-13 | 1072 | 142 | 33 | GO:0007600 |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell action potential | 5.26e-06 | 37 | 142 | 5 | GO:0086005 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1C TPTE CHRNA6 ATP13A4 KCNH7 TPCN2 ATP7A TMC2 HTR3E TMEM175 ANO5 PKDREJ CHRNA2 CHRNA3 KCND3 KCNH2 UCP1 SCN5A ANO7 PACC1 ATP13A3 STEAP1B | 7.77e-06 | 1115 | 142 | 22 | GO:0034220 |
| GeneOntologyBiologicalProcess | regulation of heart rate by cardiac conduction | 8.85e-06 | 41 | 142 | 5 | GO:0086091 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1C TPTE CHRNA6 ATP13A4 KCNH7 TPCN2 ATP7A TMC2 FLVCR1 HTR3E TMEM175 ANO5 PKDREJ CHRNA2 CHRNA3 KCND3 KCNH2 UCP1 SCN5A ANO7 PACC1 ATP13A3 STEAP1B SLC22A20P | 2.18e-05 | 1374 | 142 | 24 | GO:0006811 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 6.80e-05 | 62 | 142 | 5 | GO:0086002 | |
| GeneOntologyBiologicalProcess | membrane depolarization during atrial cardiac muscle cell action potential | 1.41e-04 | 3 | 142 | 2 | GO:0098912 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.92e-04 | 121 | 142 | 6 | GO:0051899 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 3.38e-04 | 87 | 142 | 5 | GO:0086001 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1C CHRNA6 KCNH7 TPCN2 HTR3E CHRNA2 CHRNA3 KCND3 KCNH2 SCN5A PACC1 | 6.39e-05 | 378 | 144 | 11 | GO:0034702 |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 2.42e-04 | 18 | 144 | 3 | GO:0005892 | |
| HumanPheno | Abnormal autonomic nervous system physiology | 5.61e-06 | 130 | 40 | 8 | HP:0012332 | |
| HumanPheno | Abnormality of the autonomic nervous system | RAD51 CACNA1C ATP7A VPS13C CHRNA3 FANCA MMEL1 KCNH2 SCN5A KATNIP DEPDC5 | 4.67e-05 | 346 | 40 | 11 | HP:0002270 |
| HumanPheno | Paroxysmal ventricular tachycardia | 5.02e-05 | 27 | 40 | 4 | HP:0004751 | |
| Domain | GPCR_Rhodpsn_7TM | OR51A4 OR51A2 OR5D16 NPBWR1 NPBWR2 CYSLTR2 OR2AK2 OR10A7 OR5M9 OR2M7 OR8U1 GALR1 GPR50 OR1B1 OR10P1 OR11H4 OR4E2 OR2C3 OR5K4 OR2F1 OR5AR1 OR6X1 OR8U9 OR51E2 OR52B4 OR5J2 OR5AC2 OR51M1 OR7D2 OR51I2 GPR75 OR52N4 RRH OR51V1 OR8D4 GPR119 CXCR1 | 8.71e-22 | 670 | 143 | 37 | IPR017452 |
| Domain | 7tm_1 | OR51A4 OR51A2 OR5D16 NPBWR1 NPBWR2 CYSLTR2 OR2AK2 OR10A7 OR5M9 OR2M7 OR8U1 GALR1 GPR50 OR1B1 OR10P1 OR11H4 OR4E2 OR2C3 OR5K4 OR2F1 OR5AR1 OR6X1 OR8U9 OR51E2 OR52B4 OR5J2 OR5AC2 OR51M1 OR7D2 OR51I2 GPR75 OR52N4 RRH OR51V1 OR8D4 GPR119 CXCR1 | 1.24e-21 | 677 | 143 | 37 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR51A4 OR51A2 OR5D16 NPBWR1 NPBWR2 CYSLTR2 OR2AK2 OR10A7 OR5M9 OR2M7 OR8U1 GALR1 GPR50 OR1B1 OR10P1 OR11H4 OR4E2 OR2C3 OR5K4 OR2F1 OR5AR1 OR6X1 OR8U9 OR51E2 OR52B4 OR5J2 OR5AC2 OR51M1 OR7D2 OR51I2 GPR75 OR52N4 RRH OR51V1 OR8D4 GPR119 CXCR1 | 1.85e-21 | 685 | 143 | 37 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR51A4 OR51A2 OR5D16 NPBWR1 NPBWR2 CYSLTR2 OR2AK2 OR10A7 OR5M9 OR2M7 OR8U1 GALR1 GPR50 OR1B1 OR10P1 OR11H4 OR4E2 OR2C3 OR5K4 OR2F1 OR5AR1 OR6X1 OR8U9 OR51E2 OR52B4 OR5J2 OR5AC2 OR51M1 OR7D2 OR51I2 GPR75 OR52N4 RRH OR51V1 OR8D4 GPR119 CXCR1 | 2.50e-21 | 691 | 143 | 37 | PS50262 |
| Domain | GPCR_Rhodpsn | OR51A4 OR51A2 OR5D16 NPBWR1 NPBWR2 CYSLTR2 OR2AK2 OR10A7 OR5M9 OR2M7 OR8U1 GALR1 GPR50 OR1B1 OR10P1 OR11H4 OR4E2 OR2C3 OR5K4 OR2F1 OR5AR1 OR6X1 OR8U9 OR51E2 OR52B4 OR5J2 OR5AC2 OR51M1 OR7D2 OR51I2 GPR75 OR52N4 RRH OR51V1 OR8D4 GPR119 CXCR1 | 2.62e-21 | 692 | 143 | 37 | IPR000276 |
| Domain | Olfact_rcpt | OR51A4 OR51A2 OR5D16 OR2AK2 OR10A7 OR5M9 OR2M7 OR8U1 OR1B1 OR10P1 OR11H4 OR4E2 OR2C3 OR5K4 OR2F1 OR5AR1 OR6X1 OR8U9 OR51E2 OR52B4 OR5J2 OR5AC2 OR51M1 OR7D2 OR51I2 OR52N4 OR51V1 OR8D4 | 2.04e-19 | 393 | 143 | 28 | IPR000725 |
| Domain | 7TM_GPCR_Srsx | 2.47e-05 | 112 | 143 | 7 | SM01381 | |
| Domain | - | 2.61e-05 | 23 | 143 | 4 | 1.20.120.370 | |
| Domain | Acetylcholine_rcpt_TM | 2.61e-05 | 23 | 143 | 4 | IPR027361 | |
| Domain | Ion_trans_dom | 2.77e-05 | 114 | 143 | 7 | IPR005821 | |
| Domain | Ion_trans | 2.77e-05 | 114 | 143 | 7 | PF00520 | |
| Domain | Neuropept_B/W_rcpt | 5.82e-05 | 2 | 143 | 2 | IPR009150 | |
| Domain | Ferric_reduct | 9.19e-05 | 12 | 143 | 3 | PF01794 | |
| Domain | Fe3_Rdtase_TM_dom | 9.19e-05 | 12 | 143 | 3 | IPR013130 | |
| Domain | K_chnl_volt-dep_ERG | 1.74e-04 | 3 | 143 | 2 | IPR003967 | |
| Domain | Nicotinic_acetylcholine_rcpt | 2.29e-04 | 16 | 143 | 3 | IPR002394 | |
| Domain | Cyt_b245_heavy_chain | 3.46e-04 | 4 | 143 | 2 | IPR000778 | |
| Domain | P5-ATPase | 3.46e-04 | 4 | 143 | 2 | PF12409 | |
| Domain | Neurotransmitter_ion_chnl_CS | 3.85e-04 | 45 | 143 | 4 | IPR018000 | |
| Domain | Neur_chan_memb | 4.19e-04 | 46 | 143 | 4 | PF02932 | |
| Domain | Neurotrans-gated_channel_TM | 4.55e-04 | 47 | 143 | 4 | IPR006029 | |
| Domain | - | 4.55e-04 | 47 | 143 | 4 | 2.70.170.10 | |
| Domain | Neur_chan_LBD | 4.55e-04 | 47 | 143 | 4 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 4.55e-04 | 47 | 143 | 4 | PS00236 | |
| Domain | Neur_channel | 4.55e-04 | 47 | 143 | 4 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 4.55e-04 | 47 | 143 | 4 | IPR006202 | |
| Domain | P-type_TPase_V | 5.73e-04 | 5 | 143 | 2 | IPR006544 | |
| Domain | Channel_four-helix_dom | 9.50e-04 | 57 | 143 | 4 | IPR027359 | |
| Domain | - | 9.50e-04 | 57 | 143 | 4 | 1.20.120.350 | |
| Domain | Anoct_dimer | 1.19e-03 | 7 | 143 | 2 | PF16178 | |
| Domain | Anoct_dimer | 1.19e-03 | 7 | 143 | 2 | IPR032394 | |
| Domain | NAD_binding_6 | 1.19e-03 | 7 | 143 | 2 | PF08030 | |
| Domain | FAD_binding_8 | 1.19e-03 | 7 | 143 | 2 | PF08022 | |
| Domain | FAD-bd_8 | 1.19e-03 | 7 | 143 | 2 | IPR013112 | |
| Domain | Fe_red_NAD-bd_6 | 1.19e-03 | 7 | 143 | 2 | IPR013121 | |
| Domain | - | 1.85e-03 | 32 | 143 | 3 | 3.40.1110.10 | |
| Domain | - | 1.85e-03 | 32 | 143 | 3 | 2.70.150.10 | |
| Domain | GPS | 2.21e-03 | 34 | 143 | 3 | SM00303 | |
| Domain | ATPase_P-typ_cyto_domN | 2.40e-03 | 35 | 143 | 3 | IPR023299 | |
| Domain | Anoctamin | 2.52e-03 | 10 | 143 | 2 | PF04547 | |
| Domain | Anoctamin | 2.52e-03 | 10 | 143 | 2 | IPR007632 | |
| Domain | PAS_9 | 2.52e-03 | 10 | 143 | 2 | PF13426 | |
| Domain | ATPase_P-typ_P_site | 2.61e-03 | 36 | 143 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 2.61e-03 | 36 | 143 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 2.61e-03 | 36 | 143 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.82e-03 | 37 | 143 | 3 | IPR008250 | |
| Domain | GPS | 2.82e-03 | 37 | 143 | 3 | IPR000203 | |
| Domain | E1-E2_ATPase | 2.82e-03 | 37 | 143 | 3 | PF00122 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 4.99e-03 | 14 | 143 | 2 | IPR003938 | |
| Domain | HEAT | 5.91e-03 | 48 | 143 | 3 | PF02985 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR51A4 OR51A2 OR5D16 OR2AK2 OR10A7 OR5M9 OR2M7 OR8U1 OR1B1 OR10P1 OR11H4 OR4E2 OR2C3 OR5K4 OR2F1 OR5AR1 OR6X1 OR8U9 OR51E2 OR5J2 OR5AC2 OR51M1 OR7D2 OR51I2 OR52N4 OR51V1 OR8D4 OR4K3 | 1.26e-18 | 417 | 112 | 28 | M4072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR51A4 OR51A2 OR5D16 OR2AK2 OR10A7 OR5M9 OR2M7 OR8U1 OR1B1 OR10P1 OR11H4 OR4E2 OR2C3 OR2F1 OR5AR1 OR6X1 OR51E2 OR52B4 OR5J2 OR5AC2 OR51M1 OR7D2 OR51I2 OR52N4 OR51V1 OR8D4 | 2.92e-17 | 389 | 112 | 26 | M14091 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR51A4 OR51A2 OR5D16 OR2AK2 OR10A7 OR5M9 OR2M7 OR8U1 TMC2 OR1B1 OR10P1 OR11H4 RBP1 OR4E2 OR2C3 OR5K4 OR2F1 OR5AR1 OR6X1 OR8U9 OR51E2 TAS2R16 OR5J2 OR5AC2 OR51M1 OR7D2 OR51I2 OR52N4 OR51V1 OR8D4 OR4K3 | 1.24e-16 | 636 | 112 | 31 | M41834 |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 3.96e-05 | 9 | 112 | 3 | M27597 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 3.96e-05 | 9 | 112 | 3 | MM15313 | |
| Pathway | WP_GPCRS_NONODORANT | NPBWR1 CYSLTR2 GALR1 GPR50 FZD7 TAS2R16 CELSR2 RRH GPR119 CXCR1 | 5.04e-05 | 266 | 112 | 10 | MM15843 |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 7.69e-05 | 11 | 112 | 3 | M883 | |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.02e-04 | 12 | 112 | 3 | M48008 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.02e-04 | 12 | 112 | 3 | MM15312 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 1.67e-04 | 14 | 112 | 3 | M757 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 2.07e-04 | 15 | 112 | 3 | MM14704 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 2.26e-04 | 260 | 112 | 9 | M39397 | |
| Pathway | WP_GPCRS_OTHER | 8.63e-04 | 93 | 112 | 5 | M39629 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR5D16 OR2AK2 OR5M9 OR2M7 OR8U1 OR1B1 OR10P1 OR11H4 OR4E2 OR5K4 OR2F1 OR5AR1 OR6X1 OR51E2 OR52B4 OR5J2 OR51M1 OR51I2 OR52N4 OR51V1 OR8D4 | 1.01e-18 | 340 | 144 | 21 | 11875048 |
| Pubmed | OR5D16 OR2AK2 OR5M9 OR2M7 OR8U1 OR1B1 OR10P1 OR11H4 OR4E2 OR5K4 OR2F1 OR5AR1 OR6X1 OR51E2 OR52B4 OR5J2 OR51M1 OR51I2 OR52N4 OR51V1 OR8D4 | 1.01e-18 | 340 | 144 | 21 | 11802173 | |
| Pubmed | OR5D16 OR2AK2 OR5M9 OR2M7 OR8U1 OR1B1 OR10P1 OR11H4 OR4E2 OR5K4 OR2F1 OR5AR1 OR6X1 OR51E2 OR52B4 OR5J2 OR51M1 OR51I2 OR52N4 OR51V1 OR8D4 | 1.21e-18 | 343 | 144 | 21 | 32295537 | |
| Pubmed | OR5D16 OR2AK2 OR5M9 OR2M7 OR8U1 OR1B1 OR10P1 OR11H4 OR4E2 OR5K4 OR2F1 OR5AR1 OR6X1 OR51E2 OR52B4 OR5J2 OR51M1 OR51I2 OR52N4 OR51V1 OR8D4 | 1.44e-18 | 346 | 144 | 21 | 14611657 | |
| Pubmed | OR5D16 OR2AK2 OR10A7 OR5M9 OR2M7 OR1B1 OR10P1 OR11H4 OR4E2 OR2C3 OR2F1 OR5AR1 OR6X1 OR51E2 OR52B4 OR5J2 OR51M1 OR7D2 OR51I2 OR52N4 OR51V1 OR8D4 OR4K3 | 7.55e-17 | 541 | 144 | 23 | 14983052 | |
| Pubmed | Voltage gated ion channels blockade is the underlying mechanism of BIMU8 induced cardiotoxicity. | 6.95e-08 | 3 | 144 | 3 | 28552773 | |
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 3.60e-07 | 219 | 144 | 9 | 12213199 | |
| Pubmed | 2.81e-06 | 24 | 144 | 4 | 20301690 | ||
| Pubmed | 5.73e-06 | 9 | 144 | 3 | 8906617 | ||
| Pubmed | Sources of energy for gating by neurotransmitters in acetylcholine receptor channels. | 5.73e-06 | 9 | 144 | 3 | 22647603 | |
| Pubmed | 8.17e-06 | 10 | 144 | 3 | 20736995 | ||
| Pubmed | 8.17e-06 | 10 | 144 | 3 | 26897459 | ||
| Pubmed | 8.17e-06 | 10 | 144 | 3 | 32109384 | ||
| Pubmed | 1.12e-05 | 11 | 144 | 3 | 12225896 | ||
| Pubmed | 1.19e-05 | 34 | 144 | 4 | 26378152 | ||
| Pubmed | A probabilistic classifier for olfactory receptor pseudogenes. | 1.34e-05 | 35 | 144 | 4 | 16939646 | |
| Pubmed | 1.49e-05 | 12 | 144 | 3 | 20584212 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 21996251 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 26133502 | ||
| Pubmed | Co-expression of calcium and hERG potassium channels reduces the incidence of proarrhythmic events. | 1.70e-05 | 2 | 144 | 2 | 33002116 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 20715105 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 21443946 | ||
| Pubmed | Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes. | 1.70e-05 | 2 | 144 | 2 | 22920224 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 26746457 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 16771953 | ||
| Pubmed | NOX1 and NOX4 are required for the differentiation of mouse F9 cells into extraembryonic endoderm. | 1.70e-05 | 2 | 144 | 2 | 28152080 | |
| Pubmed | Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. | 1.70e-05 | 2 | 144 | 2 | 14670934 | |
| Pubmed | Wnt is necessary for mesenchymal to epithelial transition in colorectal cancer cells. | 1.70e-05 | 2 | 144 | 2 | 28560804 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 30607529 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 19671250 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 26109178 | ||
| Pubmed | Complex Brugada syndrome inheritance in a family harbouring compound SCN5A and CACNA1C mutations. | 1.70e-05 | 2 | 144 | 2 | 25341504 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 25534702 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 23277474 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 9858824 | ||
| Pubmed | Identification of structural elements in Nox1 and Nox4 controlling localization and activity. | 1.70e-05 | 2 | 144 | 2 | 19061439 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 34755423 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 33513310 | ||
| Pubmed | Analysis of the arrhythmogenic substrate in human heart failure. | 1.70e-05 | 2 | 144 | 2 | 23036686 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 24253422 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 36421807 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 24112685 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 20457132 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 28049732 | ||
| Pubmed | Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. | 1.70e-05 | 2 | 144 | 2 | 7842012 | |
| Pubmed | ROS-generating oxidases Nox1 and Nox4 contribute to oncogenic Ras-induced premature senescence. | 1.70e-05 | 2 | 144 | 2 | 23216904 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 26222337 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 19359372 | ||
| Pubmed | Long QT interval in Turner syndrome--a high prevalence of LQTS gene mutations. | 1.70e-05 | 2 | 144 | 2 | 23936059 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 27835780 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 7590751 | ||
| Pubmed | Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. | 1.70e-05 | 2 | 144 | 2 | 24718857 | |
| Pubmed | Nrf2 regulates the expression of NOX1 in TNF-α-induced A549 cells. | 1.70e-05 | 2 | 144 | 2 | 36617822 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 26841864 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 29587244 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 38104863 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 33691909 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 18848812 | ||
| Pubmed | 1.86e-05 | 38 | 144 | 4 | 22908908 | ||
| Pubmed | 2.45e-05 | 14 | 144 | 3 | 23542581 | ||
| Pubmed | 2.45e-05 | 14 | 144 | 3 | 19059502 | ||
| Pubmed | Pacsin 2 is required for the maintenance of a normal cardiac function in the developing mouse heart. | 2.45e-05 | 14 | 144 | 3 | 29107716 | |
| Pubmed | 3.05e-05 | 15 | 144 | 3 | 11121057 | ||
| Pubmed | Analysis of nicotinic acetylcholine receptor subunits in the cochlea of the mouse. | 3.05e-05 | 15 | 144 | 3 | 8838678 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | TLCD1 NPEPPS SLC19A2 MROH1 CELSR2 XPO5 NFE2L2 MACF1 PACC1 ATP13A3 UNC93B1 WDFY3 STEAP1B FUT8 ALG6 | 3.66e-05 | 1061 | 144 | 15 | 33845483 |
| Pubmed | 3.74e-05 | 16 | 144 | 3 | 19259974 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 22933115 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 36964576 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 31696929 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 20177149 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 20116193 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 11136691 | ||
| Pubmed | Cardiac ion channel gene mutations in sudden infant death syndrome. | 5.09e-05 | 3 | 144 | 2 | 18596570 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 36709665 | ||
| Pubmed | The NADPH Oxidase Nox2 Mediates Vitamin D-Induced Vascular Regeneration in Male Mice. | 5.09e-05 | 3 | 144 | 2 | 27399878 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 15322091 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 15961404 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 27190136 | ||
| Pubmed | T-wave morphology after epinephrine bolus may reveal silent long QT syndrome mutation carriers. | 5.09e-05 | 3 | 144 | 2 | 22560601 | |
| Pubmed | Long QT syndrome-associated mutations in intrauterine fetal death. | 5.09e-05 | 3 | 144 | 2 | 23571586 | |
| Pubmed | Perturbation of ubiquitin homeostasis promotes macrophage oxidative defenses. | 5.09e-05 | 3 | 144 | 2 | 31308397 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 27200149 | ||
| Pubmed | Increased oxidative stress mediates the antitumor effect of PARP inhibition in ovarian cancer. | 5.09e-05 | 3 | 144 | 2 | 29684820 | |
| Pubmed | Genetic deletion of Nox4 enhances cancerogen-induced formation of solid tumors. | 5.09e-05 | 3 | 144 | 2 | 33836590 | |
| Pubmed | Mutation Analysis of KCNQ1, KCNH2 and SCN5A Genes in Taiwanese Long QT Syndrome Patients. | 5.09e-05 | 3 | 144 | 2 | 26118593 | |
| Pubmed | Post-mortem review and genetic analysis of sudden unexpected death in epilepsy (SUDEP) cases. | 5.09e-05 | 3 | 144 | 2 | 20875080 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 29659735 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 20877715 | ||
| Pubmed | Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. | 5.09e-05 | 3 | 144 | 2 | 22456182 | |
| Pubmed | A constitutive NADPH oxidase-like system containing gp91phox homologs in human keratinocytes. | 5.09e-05 | 3 | 144 | 2 | 15102091 | |
| Pubmed | HERG K(+) currents in human prolactin-secreting adenoma cells. | 5.09e-05 | 3 | 144 | 2 | 12634931 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 33344146 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 29449639 | ||
| Pubmed | Bimodal role of NADPH oxidases in the regulation of biglycan-triggered IL-1β synthesis. | 5.09e-05 | 3 | 144 | 2 | 26689330 | |
| Pubmed | Interaction of NADPH oxidase 1 with Toll-like receptor 2 induces migration of smooth muscle cells. | 5.09e-05 | 3 | 144 | 2 | 23749776 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 19551538 | ||
| Pubmed | Evolution and functional divergence of the anoctamin family of membrane proteins. | 5.09e-05 | 3 | 144 | 2 | 20964844 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 20407038 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 32776643 | ||
| Pubmed | Common Genotypes of Long QT Syndrome in China and the Role of ECG Prediction. | 5.09e-05 | 3 | 144 | 2 | 26496715 | |
| Interaction | GCGR interactions | 5.59e-06 | 110 | 125 | 7 | int:GCGR | |
| Interaction | GPR173 interactions | 1.58e-05 | 51 | 125 | 5 | int:GPR173 | |
| Interaction | ZNF252P-AS1 interactions | 2.22e-05 | 27 | 125 | 4 | int:ZNF252P-AS1 | |
| Interaction | OPALIN interactions | 4.87e-05 | 209 | 125 | 8 | int:OPALIN | |
| Interaction | C5AR1 interactions | 4.98e-05 | 154 | 125 | 7 | int:C5AR1 | |
| Interaction | SLC2A9 interactions | 5.02e-05 | 33 | 125 | 4 | int:SLC2A9 | |
| Cytoband | 11p15.4 | 3.56e-06 | 200 | 144 | 7 | 11p15.4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | OR51A4 OR51A2 ZNF195 ANO5 OR51E2 OR52B4 OR51M1 OR51I2 OR52N4 OR51V1 | 1.28e-05 | 564 | 144 | 10 | chr11p15 |
| GeneFamily | Olfactory receptors, family 51 | 4.12e-07 | 44 | 119 | 6 | 164 | |
| GeneFamily | Olfactory receptors, family 5 | 9.71e-05 | 112 | 119 | 6 | 152 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 1.46e-04 | 16 | 119 | 3 | 173 | |
| GeneFamily | Parkinson disease associated genes|ATPase orphan transporters | 4.24e-04 | 5 | 119 | 2 | 1213 | |
| GeneFamily | Neuropeptide receptors | 1.87e-03 | 10 | 119 | 2 | 854 | |
| GeneFamily | Anoctamins | 1.87e-03 | 10 | 119 | 2 | 865 | |
| GeneFamily | Potassium voltage-gated channels | 2.30e-03 | 40 | 119 | 3 | 274 | |
| GeneFamily | Olfactory receptors, family 8 | 4.11e-03 | 49 | 119 | 3 | 155 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 5.25e-06 | 180 | 138 | 8 | M8239 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-06 | 183 | 141 | 7 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.34e-06 | 188 | 141 | 7 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-06 | 189 | 141 | 7 | ab7ece0a517499b70b7754720d3e434765363af6 | |
| Drug | (endo-N-8-methyl-8-azabicyclo-(3.2.1)oct-3-yl)-2,3-dihydro-3-isopropyl-2-oxo-1H-benzimidazol-1-carboxamide | 2.28e-07 | 3 | 140 | 3 | ctd:C070189 | |
| Drug | pilsicainide | 9.16e-06 | 46 | 140 | 5 | CID000004820 | |
| Drug | AC1L2IZE | 1.32e-05 | 24 | 140 | 4 | CID000072928 | |
| Drug | curarine | 1.84e-05 | 26 | 140 | 4 | CID000198004 | |
| Drug | Ibutilide | 2.65e-05 | 10 | 140 | 3 | DB00308 | |
| Drug | methylenedioxydimethylamphetamine | 3.31e-05 | 30 | 140 | 4 | CID000551630 | |
| Drug | Dns-C6-Cho | 3.62e-05 | 11 | 140 | 3 | CID000124728 | |
| Drug | AC1L9NC9 | 3.62e-05 | 11 | 140 | 3 | CID000449642 | |
| Drug | dihydronereistoxin | 3.62e-05 | 11 | 140 | 3 | CID000121232 | |
| Drug | LJP 1082 | 3.62e-05 | 11 | 140 | 3 | CID003037609 | |
| Drug | bipinnatin-B | 3.62e-05 | 11 | 140 | 3 | CID000127363 | |
| Drug | Propafenone | 3.75e-05 | 2 | 140 | 2 | DB01182 | |
| Drug | 18-methoxycoronaridine | 3.75e-05 | 2 | 140 | 2 | ctd:C103345 | |
| Drug | Ajmaline | 3.75e-05 | 2 | 140 | 2 | ctd:D000404 | |
| Drug | AC1L9P8C | 4.81e-05 | 12 | 140 | 3 | CID000450864 | |
| Drug | SureCN373116 | 4.81e-05 | 12 | 140 | 3 | CID010085732 | |
| Drug | disopyramide | 5.41e-05 | 66 | 140 | 5 | CID000003114 | |
| Drug | nereistoxin | 6.22e-05 | 13 | 140 | 3 | CID000015401 | |
| Drug | 1-acetyl-4-methylpiperazine methiodide | 6.22e-05 | 13 | 140 | 3 | CID004392675 | |
| Drug | C-toxiferine-I | 6.22e-05 | 13 | 140 | 3 | CID005089093 | |
| Drug | bipinnatin-A | 6.22e-05 | 13 | 140 | 3 | CID000196603 | |
| Drug | bipinnatin-C | 6.22e-05 | 13 | 140 | 3 | CID000129977 | |
| Drug | AC1NSKJI | 6.25e-05 | 68 | 140 | 5 | CID005311391 | |
| Drug | desloratadine | 6.70e-05 | 69 | 140 | 5 | CID000124087 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 7.73e-05 | 37 | 140 | 4 | CID000009643 | |
| Drug | 2,3-dichlorooctafluorobutane | 7.88e-05 | 14 | 140 | 3 | CID000078982 | |
| Drug | LNF 209 | 7.88e-05 | 14 | 140 | 3 | CID000132666 | |
| Drug | anatoxin-a hydrochloride | 9.81e-05 | 15 | 140 | 3 | CID000135265 | |
| Drug | SAD-128 | 9.81e-05 | 15 | 140 | 3 | CID000162008 | |
| Drug | N-methylcytisine | 9.81e-05 | 15 | 140 | 3 | CID000234566 | |
| Drug | aa373 | 9.81e-05 | 15 | 140 | 3 | CID000191672 | |
| Drug | (-)-pictamine | 9.81e-05 | 15 | 140 | 3 | CID006918623 | |
| Drug | (-)-lepadin B | 9.81e-05 | 15 | 140 | 3 | CID006918624 | |
| Drug | UB-165 | 9.81e-05 | 15 | 140 | 3 | CID004694339 | |
| Drug | Ibogaine | 1.12e-04 | 3 | 140 | 2 | ctd:D007050 | |
| Drug | 3-(trifluoromethyl)-3-(m-iodophenyl)diazirine | 1.20e-04 | 16 | 140 | 3 | CID000123866 | |
| Drug | AC1L2SVN | 1.20e-04 | 16 | 140 | 3 | CID000127922 | |
| Drug | Verapamil | 1.20e-04 | 16 | 140 | 3 | DB00661 | |
| Drug | benzoquinonium | 1.20e-04 | 16 | 140 | 3 | CID000009393 | |
| Drug | PNU-282,987 | 1.20e-04 | 16 | 140 | 3 | CID004655349 | |
| Drug | bepridil | 1.31e-04 | 126 | 140 | 6 | CID000002351 | |
| Drug | Nsc36388 | 1.45e-04 | 17 | 140 | 3 | CID000014954 | |
| Drug | metoclopramide | 1.71e-04 | 84 | 140 | 5 | CID000004168 | |
| Drug | AC1O8PVM | 1.74e-04 | 18 | 140 | 3 | CID000004989 | |
| Drug | ABT-594 | 1.74e-04 | 18 | 140 | 3 | CID003075702 | |
| Drug | AC1LCVGE | 1.74e-04 | 18 | 140 | 3 | CID000656712 | |
| Drug | benzetimide | 1.74e-04 | 18 | 140 | 3 | CID000021846 | |
| Disease | Brugada Syndrome (disorder) | 3.05e-06 | 24 | 125 | 4 | C1142166 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 3.99e-05 | 16 | 125 | 3 | DOID:3635 (implicated_via_orthology) | |
| Disease | Torsades de Pointes | 5.33e-05 | 3 | 125 | 2 | C0040479 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 5.74e-05 | 157 | 125 | 6 | DOID:14330 (implicated_via_orthology) | |
| Disease | ovarian cancer (is_implicated_in) | 9.51e-05 | 56 | 125 | 4 | DOID:2394 (is_implicated_in) | |
| Disease | juvenile-onset Parkinson's disease (implicated_via_orthology) | 1.06e-04 | 4 | 125 | 2 | DOID:0060893 (implicated_via_orthology) | |
| Disease | Kufor-Rakeb syndrome (implicated_via_orthology) | 1.06e-04 | 4 | 125 | 2 | DOID:0060556 (implicated_via_orthology) | |
| Disease | traumatic brain injury (biomarker_via_orthology) | 1.41e-04 | 24 | 125 | 3 | DOID:0081292 (biomarker_via_orthology) | |
| Disease | Cardiac Arrhythmia | 1.59e-04 | 25 | 125 | 3 | C0003811 | |
| Disease | tumor necrosis factor-alpha measurement, chronic obstructive pulmonary disease | 1.77e-04 | 5 | 125 | 2 | EFO_0000341, EFO_0004684 | |
| Disease | squamous cell carcinoma | 1.91e-04 | 67 | 125 | 4 | EFO_0000707 | |
| Disease | heart conduction disease (implicated_via_orthology) | 3.36e-04 | 32 | 125 | 3 | DOID:10273 (implicated_via_orthology) | |
| Disease | long QT syndrome (is_implicated_in) | 3.69e-04 | 7 | 125 | 2 | DOID:2843 (is_implicated_in) | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_marker_for) | 3.69e-04 | 7 | 125 | 2 | DOID:0050431 (is_marker_for) | |
| Disease | Autosomal Dominant Nocturnal Frontal Lobe Epilepsy | 3.69e-04 | 7 | 125 | 2 | C3696898 | |
| Disease | Brugada syndrome | 4.90e-04 | 8 | 125 | 2 | cv:C1142166 | |
| Disease | primary ovarian insufficiency (is_implicated_in) | 4.90e-04 | 8 | 125 | 2 | DOID:5426 (is_implicated_in) | |
| Disease | JT interval | 6.76e-04 | 248 | 125 | 6 | EFO_0007885 | |
| Disease | sunburn | 7.55e-04 | 96 | 125 | 4 | EFO_0003958 | |
| Disease | Secondary Biliary Cholangitis | 7.55e-04 | 42 | 125 | 3 | C0238065 | |
| Disease | Biliary cirrhosis | 7.55e-04 | 42 | 125 | 3 | C0023892 | |
| Disease | Biliary Cirrhosis, Primary, 1 | 7.55e-04 | 42 | 125 | 3 | C4551595 | |
| Disease | susceptibility to infectious disease measurement | 7.55e-04 | 42 | 125 | 3 | EFO_0008422 | |
| Disease | Anemia, Sickle Cell | 7.84e-04 | 10 | 125 | 2 | C0002895 | |
| Disease | long QT syndrome (implicated_via_orthology) | 7.84e-04 | 10 | 125 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | Shortened QT interval | 9.55e-04 | 11 | 125 | 2 | C0151879 | |
| Disease | Congenital long QT syndrome | 9.55e-04 | 11 | 125 | 2 | cv:C1141890 | |
| Disease | Long QT Syndrome | 9.55e-04 | 11 | 125 | 2 | C0023976 | |
| Disease | suntan | 9.82e-04 | 103 | 125 | 4 | EFO_0004279 | |
| Disease | homocysteine measurement | 9.86e-04 | 46 | 125 | 3 | EFO_0004578 | |
| Disease | S-6-hydroxywarfarin measurement | 1.00e-03 | 368 | 125 | 7 | EFO_0803326 | |
| Disease | Primary biliary cirrhosis | 1.05e-03 | 47 | 125 | 3 | C0008312 | |
| Disease | TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) | 1.14e-03 | 12 | 125 | 2 | C1861063 | |
| Disease | Long QT syndrome | 1.14e-03 | 12 | 125 | 2 | cv:C0023976 | |
| Disease | Congestive heart failure | 1.25e-03 | 110 | 125 | 4 | C0018802 | |
| Disease | Heart failure | 1.25e-03 | 110 | 125 | 4 | C0018801 | |
| Disease | Left-Sided Heart Failure | 1.25e-03 | 110 | 125 | 4 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 1.25e-03 | 110 | 125 | 4 | C0235527 | |
| Disease | Heart Decompensation | 1.25e-03 | 110 | 125 | 4 | C1961112 | |
| Disease | Myocardial Failure | 1.25e-03 | 110 | 125 | 4 | C1959583 | |
| Disease | IGFBP-1 measurement | 1.35e-03 | 13 | 125 | 2 | EFO_0005118 | |
| Disease | Brugada Syndrome 1 | 1.35e-03 | 13 | 125 | 2 | C4551804 | |
| Disease | neuronal ceroid lipofuscinosis (implicated_via_orthology) | 1.57e-03 | 14 | 125 | 2 | DOID:14503 (implicated_via_orthology) | |
| Disease | T wave morphology measurement | 1.57e-03 | 14 | 125 | 2 | EFO_0008398 | |
| Disease | P wave duration | 1.80e-03 | 15 | 125 | 2 | EFO_0005094 | |
| Disease | Romano-Ward Syndrome | 2.05e-03 | 16 | 125 | 2 | C0035828 | |
| Disease | filaggrin gene expression measurement | 2.05e-03 | 16 | 125 | 2 | EFO_0020899 | |
| Disease | celiac disease | 2.06e-03 | 126 | 125 | 4 | EFO_0001060 | |
| Disease | non-alcoholic steatohepatitis (biomarker_via_orthology) | 2.32e-03 | 17 | 125 | 2 | DOID:0080547 (biomarker_via_orthology) | |
| Disease | Seizures | 2.41e-03 | 218 | 125 | 5 | C0036572 | |
| Disease | skin sensitivity to sun | 2.90e-03 | 19 | 125 | 2 | EFO_0004795 | |
| Disease | Benign Neoplasm | 3.04e-03 | 68 | 125 | 3 | C0086692 | |
| Disease | Neoplasms | 3.04e-03 | 68 | 125 | 3 | C0027651 | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 3.55e-03 | 21 | 125 | 2 | EFO_0004286, EFO_0004792 | |
| Disease | Colonic Neoplasms | 4.05e-03 | 152 | 125 | 4 | C0009375 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MLVFTLVLRSIYIVT | 151 | Q9NUN7 | |
| IFSRMRTLVATVLDF | 191 | Q96HD9 | |
| SLVVTSMVAVIVYRL | 471 | Q75V66 | |
| SMVAVIVYRLSVFAT | 476 | Q75V66 | |
| VVMLVSRLLDYVATV | 2171 | Q9NR09 | |
| EYLLFTMIFVTLSIV | 306 | P32297 | |
| FRLYLLFMASSIITV | 436 | A5X5Y0 | |
| NDITRVLYTFVLMPI | 421 | Q96PE1 | |
| FMRTTVLIADLLIYI | 111 | Q9Y672 | |
| SRIIQYLFLISVITM | 436 | Q9Y672 | |
| MAVDGTLVYIRVTLL | 1 | Q9UKJ8 | |
| MSIVSIVSSLYSIRK | 241 | Q9H7F0 | |
| IMSIISISLTVYDLR | 231 | Q4VNC1 | |
| LTEVTLMNARSELYL | 356 | Q9H9E3 | |
| SLLVSVLEYQTAVMR | 586 | P35606 | |
| MLSTYQTDFILVRER | 116 | A6NHX0 | |
| MDTILVFSLIIASYD | 1 | Q8N4C9 | |
| TTETARLRYFMELLL | 2486 | Q96DT5 | |
| YLLFTMIFVTLSIVI | 331 | Q15822 | |
| MESLFRDIYSRVVAS | 241 | A6QL63 | |
| VSMSVFLYILAARAS | 2531 | Q9HCU4 | |
| SILDCSIIRVEYSLM | 276 | Q96B67 | |
| MDVLIVLATTIAFAY | 746 | Q04656 | |
| MVESRYALLIVDSAT | 211 | Q06609 | |
| FVSYTMTVIAINFIV | 186 | O14718 | |
| ILTSYAFIIVTTLKM | 216 | Q8NGK9 | |
| LTDEVSFLRTLYEME | 311 | Q01546 | |
| LIRISQYRFTVSDLM | 121 | P51959 | |
| VSIILYRAIMAIVVS | 516 | Q6IWH7 | |
| ILMVTSATEFIRRSY | 186 | Q9Y5S8 | |
| SMFEVILTRIRSFLD | 1091 | Q7L576 | |
| RVVFRSTSAMVYIFI | 161 | O75140 | |
| EKVSSVFYTTVILML | 271 | Q8NGM9 | |
| VTDTLVIAVMALDRY | 111 | Q8NGR6 | |
| VSYTRIIITILRMSS | 216 | Q8NGE5 | |
| SMYILRSYILLLTAV | 221 | Q8NGC9 | |
| ASYARVLIVVFQMSS | 231 | Q8NG84 | |
| ITNSYTMILRAVVSL | 216 | Q8NGI2 | |
| TACVMIFTVEYLLRL | 231 | Q9UK17 | |
| SRMTVLYVDTIGFLS | 341 | O43824 | |
| MFIIDILINFRTTYV | 461 | Q9NS40 | |
| RVYVIFDLPTTVSMI | 1486 | O60303 | |
| IMFIVDILINFRTTY | 461 | Q12809 | |
| FVVSLSVADMLVAIY | 66 | Q13585 | |
| AQRTLMEALVASYLI | 476 | Q5VYK3 | |
| YLTSILEVLTRDLME | 1101 | O60486 | |
| SLVIISFVVITLSYM | 206 | Q8NHC6 | |
| MLVFPVAIIITSYAR | 206 | Q8NG81 | |
| STILLAMAFDRYVAI | 111 | Q9H255 | |
| MFISLSYFLIIRTVL | 211 | Q9H255 | |
| LSYVLILRSVMATAS | 216 | Q9H344 | |
| VFTVMLDLVLIALSY | 216 | Q9H341 | |
| SSVLLTMAFDRYIAI | 121 | Q9H2C8 | |
| MSTVVLDVVLIFISY | 206 | Q8NGK2 | |
| EIVLLISMSFDRYVA | 111 | Q96R72 | |
| QLSTLYLEVFSMLRD | 556 | Q16236 | |
| ASVLTVMLITFDRYL | 91 | Q8TDV5 | |
| AFMLSDDEIYSLRII | 886 | P50748 | |
| SLFVLFLVMYVVTVL | 26 | Q13607 | |
| VLESSVLLIMSFDRF | 111 | Q8NGJ7 | |
| VLESSVLLIMSFDRF | 111 | Q8NGJ6 | |
| TVLFIVVLSFYMVSI | 26 | Q8N628 | |
| IAMATFLTVIISYIF | 206 | Q8NH18 | |
| AYLQFMVSVATLLRE | 276 | Q495T6 | |
| SVRTLYLVSTTVDRM | 466 | Q8NDA8 | |
| LILTIMSFDRYLTIC | 111 | Q8NH79 | |
| AVMSVDRYLVVLATV | 136 | P48146 | |
| LLIVFVSYMFIISAI | 211 | P0C7N5 | |
| LVRMLSSPVESVLFY | 231 | P14923 | |
| AVVSVSYIMIAQTLR | 216 | O95800 | |
| ITQEFMDLRTRYTAL | 1381 | Q9UPN3 | |
| MDLRTRYTALVTLTT | 1386 | Q9UPN3 | |
| LFLMITASTYAIRVS | 171 | Q9NPH5 | |
| VAMEYLQSASRILTR | 366 | Q15256 | |
| LLMAVAVFLVYRTIT | 76 | Q9H813 | |
| PTLMTIIISYTRVLF | 211 | Q9NZP5 | |
| SLVLVEMTITSFYAV | 111 | Q86UW1 | |
| ASTLFTVLTYLVDMR | 266 | O75084 | |
| VSIFTLAAMSVDRYV | 121 | P47211 | |
| YLLFTMIFVTLSIVV | 306 | Q15825 | |
| AYRFQAIITTFEMIL | 966 | Q3L8U1 | |
| VYEILRLLVTDMSDA | 331 | O14929 | |
| TSIFTLEIILKMTAY | 961 | Q13936 | |
| ETLRLAIVYISFMTE | 141 | Q96RJ6 | |
| TSLYRRLFVMLSAEE | 356 | O15360 | |
| SSLTLREFYMAFQVV | 231 | Q6MZW2 | |
| LSFMSYDEISQLRLV | 76 | Q9NVF7 | |
| LSYIMALTRILAEAE | 86 | Q8N100 | |
| MLVILYSRVGRSVTD | 61 | P25024 | |
| LDSRDVVMIIIFGYS | 421 | Q5VV63 | |
| IGMVIFTFTLDLRYI | 411 | Q9Y5Y0 | |
| GVSRSVTLVIAYIMT | 91 | Q9NRW4 | |
| AYIMLAVEVRSLSSL | 391 | Q96T53 | |
| RTSYLAAFAIMVIFT | 301 | Q4ZIN3 | |
| VTFRAMSARLLDYVV | 646 | Q63ZY3 | |
| ELRFAYMVTTVLLSV | 411 | Q6UW02 | |
| AIVVCALIISTFYMR | 351 | Q96HH9 | |
| MIYVGRRATVASFLI | 391 | A6NK97 | |
| FRIIYMLLITIATFQ | 396 | O60779 | |
| ARTPVMSTYLVAFVV | 236 | P55786 | |
| MTLTRVELLTFQERY | 166 | Q9BXL7 | |
| YLGIINMFFIRETTS | 891 | Q86YS7 | |
| IMIRSIFLFLDRTYV | 301 | Q13620 | |
| FLTVMSADRYLVVLA | 126 | P48145 | |
| TDRVLSLFYTVITPM | 271 | Q8NGE3 | |
| SLLERNITVTMYITI | 181 | Q9ULK6 | |
| LLIVFVSYMFIISAI | 211 | Q8NH10 | |
| FMIAYGTQRTLILES | 231 | Q9BYC5 | |
| LTVFFMIIYVLESLT | 6 | Q9NYV7 | |
| IMESRILTFLETYLA | 441 | Q9NUJ3 | |
| RIFAYLMAVILSVTL | 161 | Q96D59 | |
| LSDVTLMISVYNRRT | 586 | Q17RD7 | |
| YLVTSLILVVTMAIL | 271 | Q96NR3 | |
| IIRTLSTFRNYIMDF | 51 | P09455 | |
| LTTALSMIVYRSIKE | 266 | Q8TBE7 | |
| IVTEVMVLFTVLVYT | 1001 | Q9NTG1 | |
| LRMLSIVSEVLSYLQ | 351 | Q8NB12 | |
| LDFSVIIMAYTTEFV | 196 | Q14524 | |
| DTLLLTVMAYDRFVA | 111 | Q96RA2 | |
| ISYTFILVAIIRMRS | 216 | Q8NGP9 | |
| YTLIVVAVLRMRSAD | 216 | Q8NGP3 | |
| LLFVVFSAIYLVTMV | 26 | A6NMS3 | |
| VMASLTFLYTLLREV | 61 | Q6NZ63 | |
| LIVTIREVEMLYSFF | 546 | Q8N957 | |
| IYFLTVLSVVRFLAM | 126 | Q9NS75 | |
| LMYLFVITAEDRQVS | 236 | O75153 | |
| EVMSIRTTNREYFLI | 96 | Q5SXH7 | |
| LMRSVIINCTELVTY | 181 | P25874 | |
| RFLMSYLNEVRSTEV | 426 | Q8WUH2 | |
| DLDLTYVTERIIAMS | 236 | P56180 | |
| QRFLTADMALVATVY | 641 | Q2NL82 | |
| LVTLVAAAVSYLRME | 501 | Q9H1C4 | |
| NVLSEFVMSEIRTVY | 601 | Q5T7W0 | |
| TRIAVYLMTFLIVTV | 76 | Q9BSA9 | |
| FVYITSLLVAMERSL | 651 | Q8IZQ1 | |
| FLAVVTSYMVILVSL | 211 | Q8NGC2 | |
| MFSVITSYILFRATR | 111 | Q8N4F7 | |
| LTLLYITRVEDIIME | 251 | O95858 | |
| TVLERMQRFFSTLYE | 831 | Q9HAV4 | |
| ATMRTFDLTVVSYLK | 946 | Q709C8 | |
| VMIIIYFSRLLRSDF | 216 | Q96CP7 | |
| SRLITLYLTMLVTFT | 156 | Q7Z3V4 | |
| VSVFGYSLIIVIRSM | 346 | Q8TDI7 | |
| RVVLMVFSLVSVTYG | 201 | Q6PP77 | |
| LTFLLRPETVSMVIY | 341 | Q05996 | |
| MTLLTFRDVAIEFSL | 1 | O14628 | |
| ATYQMTVELLFRDIL | 716 | Q8NHX9 | |
| RVVVLLDISATNSMY | 511 | A6NCI4 | |
| VMLRSSREAAFVYAI | 131 | Q93097 | |
| RVTTMVDGRYLVVSL | 726 | Q9BRZ2 |